The $35 Million Lie Your Doctor Still Believes
Most people have never heard of the STAR*D trial but it’s the single most influential antidepressant study ever conducted. It ran from 2001 to 2006, cost $35 million, and produced the claim that 67% of depressed patients can reach remission if they try up to 4 different medications. That number became gospel in psychiatry. It’s the reason your doctor tells you “if this one doesn’t work we’ll just try another one.” And guess who makes billions of dollars off you using these drugs like a lab rat? You guessed it, big pharma!

That 67% number appears to be absolute fraud. In 2023 independent researchers reanalyzed the raw data according to the study’s own original protocol and found the investigators had changed the rules mid study. They included over 900 patients who should have been excluded, swapped out the objective clinician rated scale for a subjective self report that produced better numbers, and excluded 234 patients who dropped out on citalopram, conveniently dodging any obligation to report emerging suicidality. When corrected, remission drops to 35%! Half of what was reported. And there was no placebo group at any step, so even that 35% can’t be attributed to the drugs.

The real bombshell is sustained remission. People who actually got better and stayed better at 12 months? Only between 3% and 8%! That’s the long term success rate of the most important antidepressant study in history. That’s absolutely shocking.

When independent researchers requested the raw data, the STAR*D investigators refused to hand it over. The reanalysis only happened because an outside organization went around them through an NIMH data access request. And these investigators had financial ties to virtually every major antidepressant manufacturer.

Lead researcher Dr. Rush had relationships with Eli Lilly, GlaxoSmithKline, Pfizer, Bristol-Myers Squibb, and owned Pfizer stock. Co-lead Dr. Trivedi took consulting fees from AstraZeneca, Eli Lilly, GlaxoSmithKline, Janssen, Johnson & Johnson, and Pfizer.
These are the people who designed the study, manipulated the data, and wrote the conclusions that shaped how tens of millions of Americans get treated.

For 17 years nobody checked the math. When someone finally did, the results were inflated by 91%, the investigators fought to keep the data hidden, and the exposed long term success rate was in the single digits. This is the study your doctor’s treatment plan is based on.

BMJ Open reanalysis (2023): https://bmjopen.bmj.com/content/13/7/e063095
Psychiatric Times (2023): https://www.psychiatrictimes.com/view/star-d-dethroned
Psychiatric Times (2025): https://www.psychiatrictimes.com/…/star-d-s-cumulative…
STAR*D investigator conflicts of interest: https://www.ccjm.org/content/75/1/57